»ùÇà ¿äû ¸ñ·Ï¿¡ Ãß°¡
¿¤¶ó½ºÅä¸Ó ÁÖÀÔ ÆßÇÁ ½ÃÀå(2023-2027³â)
¿¤¶ó½ºÅä¸Ó ÁÖÀÔ ÆßÇÁ ½ÃÀåÀº 2022-2027³â¿¡ 8¾ï 97¸¸ ´Þ·¯, ¿¹Ãø±â°£ Áß CAGRÀº 7.07%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ¿¤¶ó½ºÅä¸Ó ÁÖÀÔ ÆßÇÁ ½ÃÀåÀÇ ÀüüÀûÀÎ ºÐ¼®, ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø, µ¿Çâ, ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ, °úÁ¦, ¾à 25°³ º¥´õ¸¦ Æ÷ÇÔÇÑ º¥´õ ºÐ¼® µîÀ» Á¦°øÇÕ´Ï´Ù.
ÇöÀç ½ÃÀå ½Ã³ª¸®¿À, Ãֽе¿Çâ°ú ÃËÁø¿äÀÎ, ½ÃÀå ȯ°æ Àüü¿¡ °üÇÑ ÃֽŠºÐ¼®À» Á¦°øÇÕ´Ï´Ù. ¸¸¼ºÁúȯ Áõ°¡, ½ÃÀå ÁøÃâ ±â¾÷ °£ÀÇ ÀμöÇÕº´, º¥´õ¿¡ ÀÇÇÑ ¿¬±¸°³¹ß ÅõÀÚ Áõ°¡ µîÀÌ ½ÃÀåÀ» °ßÀÎÇϰí ÀÖ½À´Ï´Ù.
ÀÌ Á¶»ç¿¡¼´Â ÇâÈÄ ¸î ³â°£ ¿¤¶ó½ºÅä¸Ó ÁÖÀÔ ÆßÇÁ ½ÃÀå ¼ºÀåÀ» °ßÀÎÇÏ´Â ÁÖ¿ä ¿äÀÎ Áß Çϳª·Î °íµµ ÁÖÀÔ ÆßÇÁ¿¡ ´ëÇÑ ³ôÀº ¼ö¿ä¸¦ µé°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ ÇコÄÉ¾î »ê¾÷ÀÇ °ßÁ¶ÇÑ ¼ºÀå°ú ÀçÅÃÀÇ·á ¼ö¿ä Áõ°¡°¡ ½ÃÀåÀÇ Å« ¼ö¿ä·Î À̾îÁý´Ï´Ù.
¸ñÂ÷
Á¦1Àå ÁÖ¿ä ¿ä¾à
Á¦2Àå ½ÃÀå »óȲ
Á¦3Àå ½ÃÀå ±Ô¸ð
½ÃÀåÀÇ Á¤ÀÇ
½ÃÀå ºÎ¹® ºÐ¼®
½ÃÀå ±Ô¸ð 2022
½ÃÀå Àü¸Á 2022-2027
Á¦4Àå ½ÃÀå ±Ô¸ð ½ÇÀû
¿¤¶ó½ºÅä¸Ó ÁÖÀÔ ÆßÇÁ ½ÃÀå 2017-2021
¿ëµµº° ºÎ¹® ºÐ¼® 2017-2021
ÃÖÁ¾»ç¿ëÀÚ ºÎ¹® ºÐ¼® 2017-2021
Áö¿ªº° ºÎ¹® ºÐ¼® 2017-2021
±¹°¡º° ºÎ¹® ºÐ¼® 2017-2021
Á¦5Àå Five Forces ºÐ¼®
Five Forces ¿ä¾à
±¸¸ÅÀÚÀÇ ±³¼··Â
°ø±Þ ±â¾÷ÀÇ ±³¼··Â
½Å±Ô Âü¿©¾÷üÀÇ À§Çù
´ëüǰÀÇ À§Çù
°æÀïÀÇ À§Çù
½ÃÀå »óȲ
Á¦6Àå ½ÃÀå ¼¼ºÐÈ : ¿ëµµº°
½ÃÀå ºÎ¹®
ºñ±³ : ¿ëµµº°
ÅëÁõ °ü¸® : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2022-2027
Ç×»ýÁ¦ ¶Ç´Â Ç×¹ÙÀÌ·¯½ºÁ¦ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2022-2027
ÈÇпä¹ý : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2022-2027
±âŸ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2022-2027
½ÃÀå ±âȸ : ¿ëµµº°
Á¦7Àå ½ÃÀå ¼¼ºÐÈ : ÃÖÁ¾»ç¿ëÀÚº°
½ÃÀå ºÎ¹®
ºñ±³ : ÃÖÁ¾»ç¿ëÀÚº°
º´¿ø : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2022-2027
¿Ü·¡ ¼ºñ½º ¼¾ÅÍ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2022-2027
Ŭ¸®´Ð : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2022-2027
±âŸ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2022-2027
½ÃÀå ±âȸ : ÃÖÁ¾»ç¿ëÀÚº°
Á¦8Àå °í°´ »óȲ
Á¦9Àå Áö¿ªº° »óȲ
Áö¿ªº° ¼¼ºÐÈ
Áö¿ªº° ºñ±³
ºÏ¹Ì : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2022-2027
À¯·´ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2022-2027
¾Æ½Ã¾Æ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2022-2027
¼¼°è ±âŸ Áö¿ª : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2022-2027
¹Ì±¹ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2022-2027
µ¶ÀÏ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2022-2027
¿µ±¹ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2022-2027
ij³ª´Ù : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2022-2027
Áß±¹ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2022-2027
½ÃÀå ±âȸ : Áö¿ª »óȲº°
Á¦10Àå ÃËÁø¿äÀÎ, °úÁ¦ ¹× µ¿Çâ
½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
½ÃÀå °úÁ¦
¼ºÀå ÃËÁø¿äÀΰú °úÁ¦ÀÇ ¿µÇâ
½ÃÀå µ¿Çâ
Á¦11Àå º¥´õ »óȲ
°³¿ä
º¥´õ »óȲ
È¥¶õ »óȲ
¾÷°è À§Çè
Á¦12Àå º¥´õ ºÐ¼®
´ë»ó º¥´õ
º¥´õÀÇ ½ÃÀå Æ÷Áö¼Å´×
Ambu AS
Avanos Medical Inc
B.Braun SE
Baxter International Inc.
Daiken Medical Co. Ltd.
Epic Medical
Fresenius SE and Co. KGaA
Medline Industries LP
MicroPort Scientific Corp.
Nipro Corp.
pfm medical ag
Promecon
Vygon SAS
Werfenlife SA
WooYoung Medical Co. Ltd.
Á¦13Àå ºÎ·Ï
KSM
Elastomeric Infusion Pumps Market 2023-2027
The elastomeric infusion pumps market is forecasted to grow by USD 800.97 mn during 2022-2027, accelerating at a CAGR of 7.07% during the forecast period. The report on the elastomeric infusion pumps market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence of chronic diseases, mergers and acquisitions among market players, and increased investments by vendors in R&D.
Technavio's elastomeric infusion pumps market is segmented as below:
By Application
Pain management
Antibiotic or antiviral
Chemotherapy
Others
By End-user
Hospitals
Ambulatory service centers
Clinics
Others
By Geographical Landscape
North America
Europe
Asia
Rest of World (ROW)
This study identifies the high demand for advanced infusion pumps as one of the prime reasons driving the elastomeric infusion pumps market growth during the next few years. Also, robust growth of healthcare industry and increased demand for home-based healthcare will lead to sizable demand in the market.
The report on the elastomeric infusion pumps market covers the following areas:
Elastomeric infusion pumps market sizing
Elastomeric infusion pumps market forecast
Elastomeric infusion pumps market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading elastomeric infusion pumps market vendors that include Ambu AS, Avanos Medical Inc, B.Braun SE, Baxter International Inc., Daiken Medical Co. Ltd., Epic Medical, Fresenius SE and Co. KGaA, Heka srls, Infusystem Holdings Inc., Medline Industries LP, MicroPort Scientific Corp., Mindray Bio medical Electronics Co. Ltd., Nipro Corp., Owens and Minor Inc., pfm medical ag, Promecon, Smiths Group Plc, Vygon SAS, Werfenlife SA, and WooYoung Medical Co. Ltd.. Also, the elastomeric infusion pumps market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Application
Exhibit 06: Executive Summary - Chart on Market Segmentation by End-user
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
2 Market Landscape
2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics
3 Market Sizing
3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2022
3.4 Market outlook: Forecast for 2022-2027
Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
4 Historic Market Size
4.1 Elastomeric infusion pumps market 2017 - 2021
Exhibit 18: Historic Market Size - Data Table on elastomeric infusion pumps market 2017 - 2021 ($ million)
4.2 Application Segment Analysis 2017 - 2021
Exhibit 19: Historic Market Size - Application Segment 2017 - 2021 ($ million)
4.3 End user Segment Analysis 2017 - 2021
Exhibit 20: Historic Market Size - End user Segment 2017 - 2021 ($ million)
4.4 Geography Segment Analysis 2017 - 2021
Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
4.5 Country Segment Analysis 2017 - 2021
Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
5 Five Forces Analysis
5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2022 and 2027
6 Market Segmentation by Application
6.1 Market segments
Exhibit 30: Chart on Application - Market share 2022-2027 (%)
Exhibit 31: Data Table on Application - Market share 2022-2027 (%)
6.2 Comparison by Application
Exhibit 32: Chart on Comparison by Application
Exhibit 33: Data Table on Comparison by Application
6.3 Pain management - Market size and forecast 2022-2027
Exhibit 34: Chart on Pain management - Market size and forecast 2022-2027 ($ million)
Exhibit 35: Data Table on Pain management - Market size and forecast 2022-2027 ($ million)
Exhibit 36: Chart on Pain management - Year-over-year growth 2022-2027 (%)
Exhibit 37: Data Table on Pain management - Year-over-year growth 2022-2027 (%)
6.4 Antibiotic or antiviral - Market size and forecast 2022-2027
Exhibit 38: Chart on Antibiotic or antiviral - Market size and forecast 2022-2027 ($ million)
Exhibit 39: Data Table on Antibiotic or antiviral - Market size and forecast 2022-2027 ($ million)
Exhibit 40: Chart on Antibiotic or antiviral - Year-over-year growth 2022-2027 (%)
Exhibit 41: Data Table on Antibiotic or antiviral - Year-over-year growth 2022-2027 (%)
6.5 Chemotherapy - Market size and forecast 2022-2027
Exhibit 42: Chart on Chemotherapy - Market size and forecast 2022-2027 ($ million)
Exhibit 43: Data Table on Chemotherapy - Market size and forecast 2022-2027 ($ million)
Exhibit 44: Chart on Chemotherapy - Year-over-year growth 2022-2027 (%)
Exhibit 45: Data Table on Chemotherapy - Year-over-year growth 2022-2027 (%)
6.6 Others - Market size and forecast 2022-2027
Exhibit 46: Chart on Others - Market size and forecast 2022-2027 ($ million)
Exhibit 47: Data Table on Others - Market size and forecast 2022-2027 ($ million)
Exhibit 48: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibit 49: Data Table on Others - Year-over-year growth 2022-2027 (%)
6.7 Market opportunity by Application
Exhibit 50: Market opportunity by Application ($ million)
Exhibit 51: Data Table on Market opportunity by Application ($ million)
7 Market Segmentation by End-user
7.1 Market segments
Exhibit 52: Chart on End-user - Market share 2022-2027 (%)
Exhibit 53: Data Table on End-user - Market share 2022-2027 (%)
7.2 Comparison by End-user
Exhibit 54: Chart on Comparison by End-user
Exhibit 55: Data Table on Comparison by End-user
7.3 Hospitals - Market size and forecast 2022-2027
Exhibit 56: Chart on Hospitals - Market size and forecast 2022-2027 ($ million)
Exhibit 57: Data Table on Hospitals - Market size and forecast 2022-2027 ($ million)
Exhibit 58: Chart on Hospitals - Year-over-year growth 2022-2027 (%)
Exhibit 59: Data Table on Hospitals - Year-over-year growth 2022-2027 (%)
7.4 Ambulatory service centers - Market size and forecast 2022-2027
Exhibit 60: Chart on Ambulatory service centers - Market size and forecast 2022-2027 ($ million)
Exhibit 61: Data Table on Ambulatory service centers - Market size and forecast 2022-2027 ($ million)
Exhibit 62: Chart on Ambulatory service centers - Year-over-year growth 2022-2027 (%)
Exhibit 63: Data Table on Ambulatory service centers - Year-over-year growth 2022-2027 (%)
7.5 Clinics - Market size and forecast 2022-2027
Exhibit 64: Chart on Clinics - Market size and forecast 2022-2027 ($ million)
Exhibit 65: Data Table on Clinics - Market size and forecast 2022-2027 ($ million)
Exhibit 66: Chart on Clinics - Year-over-year growth 2022-2027 (%)
Exhibit 67: Data Table on Clinics - Year-over-year growth 2022-2027 (%)
7.6 Others - Market size and forecast 2022-2027
Exhibit 68: Chart on Others - Market size and forecast 2022-2027 ($ million)
Exhibit 69: Data Table on Others - Market size and forecast 2022-2027 ($ million)
Exhibit 70: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibit 71: Data Table on Others - Year-over-year growth 2022-2027 (%)
7.7 Market opportunity by End-user
Exhibit 72: Market opportunity by End-user ($ million)
Exhibit 73: Data Table on Market opportunity by End-user ($ million)
8 Customer Landscape
8.1 Customer landscape overview
Exhibit 74: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape
9.1 Geographic segmentation
Exhibit 75: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibit 76: Data Table on Market share By Geographical Landscape 2022-2027 (%)
9.2 Geographic comparison
Exhibit 77: Chart on Geographic comparison
Exhibit 78: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2022-2027
Exhibit 79: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 80: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 81: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibit 82: Data Table on North America - Year-over-year growth 2022-2027 (%)
9.4 Europe - Market size and forecast 2022-2027
Exhibit 83: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 84: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 85: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibit 86: Data Table on Europe - Year-over-year growth 2022-2027 (%)
9.5 Asia - Market size and forecast 2022-2027
Exhibit 87: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 88: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 89: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibit 90: Data Table on Asia - Year-over-year growth 2022-2027 (%)
9.6 Rest of World (ROW) - Market size and forecast 2022-2027
Exhibit 91: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 92: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 93: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibit 94: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
9.7 US - Market size and forecast 2022-2027
Exhibit 95: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibit 96: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibit 97: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibit 98: Data Table on US - Year-over-year growth 2022-2027 (%)
9.8 Germany - Market size and forecast 2022-2027
Exhibit 99: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 100: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 101: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibit 102: Data Table on Germany - Year-over-year growth 2022-2027 (%)
9.9 UK - Market size and forecast 2022-2027
Exhibit 103: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 104: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 105: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibit 106: Data Table on UK - Year-over-year growth 2022-2027 (%)
9.10 Canada - Market size and forecast 2022-2027
Exhibit 107: Chart on Canada - Market size and forecast 2022-2027 ($ million)
Exhibit 108: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
Exhibit 109: Chart on Canada - Year-over-year growth 2022-2027 (%)
Exhibit 110: Data Table on Canada - Year-over-year growth 2022-2027 (%)
9.11 China - Market size and forecast 2022-2027
Exhibit 111: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibit 112: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibit 113: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibit 114: Data Table on China - Year-over-year growth 2022-2027 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 115: Market opportunity By Geographical Landscape ($ million)
Exhibit 116: Data Tables on Market opportunity By Geographical Landscape ($ million)
10 Drivers, Challenges, and Trends
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 117: Impact of drivers and challenges in 2022 and 2027
10.4 Market trends
11 Vendor Landscape
11.1 Overview
11.2 Vendor landscape
Exhibit 118: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 119: Overview on factors of disruption
11.4 Industry risks
Exhibit 120: Impact of key risks on business
12 Vendor Analysis
12.1 Vendors covered
Exhibit 121: Vendors covered
12.2 Market positioning of vendors
Exhibit 122: Matrix on vendor position and classification
12.3 Ambu AS
Exhibit 123: Ambu AS - Overview
Exhibit 124: Ambu AS - Business segments
Exhibit 125: Ambu AS - Key offerings
Exhibit 126: Ambu AS - Segment focus
12.4 Avanos Medical Inc
Exhibit 127: Avanos Medical Inc - Overview
Exhibit 128: Avanos Medical Inc - Business segments
Exhibit 129: Avanos Medical Inc - Key offerings
Exhibit 130: Avanos Medical Inc - Segment focus
12.5 B.Braun SE
Exhibit 131: B.Braun SE - Overview
Exhibit 132: B.Braun SE - Business segments
Exhibit 133: B.Braun SE - Key news
Exhibit 134: B.Braun SE - Key offerings
Exhibit 135: B.Braun SE - Segment focus
12.6 Baxter International Inc.
Exhibit 136: Baxter International Inc. - Overview
Exhibit 137: Baxter International Inc. - Business segments
Exhibit 138: Baxter International Inc. - Key news
Exhibit 139: Baxter International Inc. - Key offerings
Exhibit 140: Baxter International Inc. - Segment focus
12.7 Daiken Medical Co. Ltd.
Exhibit 141: Daiken Medical Co. Ltd. - Overview
Exhibit 142: Daiken Medical Co. Ltd. - Product / Service
Exhibit 143: Daiken Medical Co. Ltd. - Key offerings
12.8 Epic Medical
Exhibit 144: Epic Medical - Overview
Exhibit 145: Epic Medical - Product / Service
Exhibit 146: Epic Medical - Key offerings
12.9 Fresenius SE and Co. KGaA
Exhibit 147: Fresenius SE and Co. KGaA - Overview
Exhibit 148: Fresenius SE and Co. KGaA - Business segments
Exhibit 149: Fresenius SE and Co. KGaA - Key news
Exhibit 150: Fresenius SE and Co. KGaA - Key offerings
Exhibit 151: Fresenius SE and Co. KGaA - Segment focus
12.10 Medline Industries LP
Exhibit 152: Medline Industries LP - Overview
Exhibit 153: Medline Industries LP - Product / Service
Exhibit 154: Medline Industries LP - Key offerings
12.11 MicroPort Scientific Corp.
Exhibit 155: MicroPort Scientific Corp. - Overview
Exhibit 156: MicroPort Scientific Corp. - Business segments
Exhibit 157: MicroPort Scientific Corp. - Key offerings
Exhibit 158: MicroPort Scientific Corp. - Segment focus
12.12 Nipro Corp.
Exhibit 159: Nipro Corp. - Overview
Exhibit 160: Nipro Corp. - Business segments
Exhibit 161: Nipro Corp. - Key offerings
Exhibit 162: Nipro Corp. - Segment focus
12.13 pfm medical ag
Exhibit 163: pfm medical ag - Overview
Exhibit 164: pfm medical ag - Product / Service
Exhibit 165: pfm medical ag - Key offerings
12.14 Promecon
Exhibit 166: Promecon - Overview
Exhibit 167: Promecon - Product / Service
Exhibit 168: Promecon - Key offerings
12.15 Vygon SAS
Exhibit 169: Vygon SAS - Overview
Exhibit 170: Vygon SAS - Product / Service
Exhibit 171: Vygon SAS - Key offerings
12.16 Werfenlife SA
Exhibit 172: Werfenlife SA - Overview
Exhibit 173: Werfenlife SA - Product / Service
Exhibit 174: Werfenlife SA - Key offerings
12.17 WooYoung Medical Co. Ltd.
Exhibit 175: WooYoung Medical Co. Ltd. - Overview
Exhibit 176: WooYoung Medical Co. Ltd. - Product / Service
Exhibit 177: WooYoung Medical Co. Ltd. - Key offerings
13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 178: Inclusions checklist
Exhibit 179: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 180: Currency conversion rates for US$
13.4 Research methodology
Exhibit 181: Research methodology
Exhibit 182: Validation techniques employed for market sizing
Exhibit 183: Information sources
13.5 List of abbreviations
Exhibit 184: List of abbreviations